Nutex Health Inc.
NUTX
$44.66
-$1.84-3.96%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 292.00M | 275.93M | 258.77M | 247.65M | 231.70M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 292.00M | 275.93M | 258.77M | 247.65M | 231.70M |
| Cost of Revenue | 205.78M | 204.78M | 200.90M | 195.28M | 197.28M |
| Gross Profit | 86.22M | 71.15M | 57.87M | 52.37M | 34.42M |
| SG&A Expenses | 40.26M | 36.28M | 35.70M | 36.07M | 29.39M |
| Depreciation & Amortization | 18.37M | 18.15M | 17.78M | 17.59M | 16.18M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 264.42M | 259.21M | 254.38M | 248.94M | 242.85M |
| Operating Income | 27.58M | 16.72M | 4.39M | -1.29M | -11.15M |
| Income Before Tax | -29.54M | -31.82M | -40.81M | -48.49M | -26.63M |
| Income Tax Expenses | 2.87M | -2.06M | -3.77M | -5.07M | -263.40K |
| Earnings from Continuing Operations | -32.41 | -29.77 | -37.04 | -43.42 | -26.37 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -8.73M | -8.12M | -3.96M | -2.36M | -2.55M |
| Net Income | -41.13M | -37.89M | -41.00M | -45.79M | -28.92M |
| EBIT | 27.58M | 16.72M | 4.39M | -1.29M | -11.15M |
| EBITDA | 36.20M | 25.17M | 12.38M | 6.25M | -5.51M |
| EPS Basic | -9.37 | -8.90 | -9.62 | -10.73 | -6.23 |
| Normalized Basic EPS | -0.91 | -1.24 | -2.44 | -3.14 | -4.10 |
| EPS Diluted | -9.76 | -9.28 | -10.00 | -11.10 | -6.50 |
| Normalized Diluted EPS | -0.91 | -1.24 | -2.44 | -3.14 | -4.10 |
| Average Basic Shares Outstanding | 19.13M | 18.47M | 17.88M | 17.37M | 18.07M |
| Average Diluted Shares Outstanding | 19.13M | 18.47M | 17.88M | 17.37M | 18.07M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -1.17% | -1.27% | -3.98% | -5.87% | -9.29% |
